|
|
Volumn 84, Issue 5, 2009, Pages 313-314
|
|
Cyclosporine therapy in refractory/relapsed patients with thrombotic thrombocytopenic purpura
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOSPORIN;
IMMUNOGLOBULIN;
POLYETHYLENE;
RITUXIMAB;
STEROID;
VINCRISTINE SULFATE;
VON WILLEBRAND FACTOR CLEAVING PROTEINASE;
ABSENCE OF SIDE EFFECTS;
DISEASE SEVERITY;
DRUG BLOOD LEVEL;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG WITHDRAWAL;
ENZYME ACTIVITY;
HUMAN;
LETTER;
PATIENT MONITORING;
PRIORITY JOURNAL;
REFRACTORY THROMBOCYTOPENIA;
RELAPSE;
REMISSION;
RISK REDUCTION;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
TREATMENT DURATION;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
VON WILLEBRAND DISEASE;
CYCLOSPORINE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
PURPURA, THROMBOTIC THROMBOCYTOPENIC;
RECURRENCE;
REMISSION INDUCTION;
TREATMENT OUTCOME;
|
|
EID: 65649152998
PISSN: 03618609
EISSN: 10968652
Source Type: Journal
DOI: 10.1002/ajh.21385 Document Type: Letter |
|
Times cited : (28)
|
|
References (6)
|
